Printer Friendly

ANTIBODY RESPONSE OF RABBITS TO COMBINED HEMORRHAGIC SEPTICEMIA AND FOOT and MOUTH DISEASE VIRUS VACCINE.

Byline: I. Altaf, M. Siddique, K. Muhammad, M. Irshad, M. Z. Khan, A. A. Anjum and M. Kamran

ABSTRACT

Infectious diseases particularly Foot and Mouth Disease (FMD) and Hemorrhagic septicemia (HS) are challenge for livestock and dairy industry all over the world and cause great economic losses. Vaccination programs using monovalent vaccines against the diseases are effective but the repeated vaccination induces stress to the animals and increase cost of vaccination for the farmer. In this study, efficacy of bivalent FMD+HS vaccine was compared to monovalent FMD and HS vaccines in rabbits. Previously isolated and characterized FMD virus "O" serotype and Pasteurella multocida were used in the experimental design. Alum precipitated FMD, HS and FMD+HS vaccines were prepared and injected in experimental rabbits (6 months of age) at 0 and 14th day. The serum samples were collected on 0, 14, 28, 35 and 48 days post-priming. Antibody titer was measured by Virus Neutralization (V/N) for FMD "O" virus and Indirect Hemagglutination (IHA) test for lipopolysaccharide (LPS) of Pasteurella multocida.

The results showed that peak level of Geometric mean antibody titer (50.8 VN units and 40.3 IHA units) was obtained on 35th day in both the monovalent FMD and HS vaccine, respectively whereas in bivalent FMD+HS vaccine peak level of GMT antibody titer (161.3 VN units +50.8 IHA units) was detected on 48th days post-priming. It is concluded that combine bivalent vaccine produced better antibody titer that persisted for longer time.

Key words: Food and Mouth Disease, Pasteurella multocida, Monovalent, Bivalent.

INTRODUCTION

Bacterial and viral diseases cause enormous economic loss through morbidity and mortality to livestock which contribute 39% of agriculture value added and about 9.4% of GDP. About 35 million people are deriving 20-25% income from livestock.

Hemorrhagic septicemia (HS) is an important bacterial disease of cattle and buffaloes occurring in many Asian and African countries, resulting in high mortality and morbidity. In many Asian countries like Pakistan, disease outbreaks mostly occur during the change in climatic conditions typical of monsoon. The disease is caused by Pasteurella multocida, a gram- negative coco-bacillus and aerobic residing mostly in the upper respiratory tract of animals. Foot and Mouth disease (FMD), a highly contagious viral disease affecting primarily cloven footed animals and is of most concern all over the world (Pereira, 1981). The causative agent (virus) belongs to the genus apthovirus of Picornaviridae (Dietzschold and Ahl, 1970). In Pakistan, the most prevalent serotypes are O (70%), Asia-I (25%) and A (4.67%) causing a loss of Rs. 6.00 billions to farmers annually (Awan et al., 2009; Khawaja et al.,2009).

Vaccination is an important tool to control the infectious diseases and is considered as effective method to control the diseases (Salt et al., 1999; Sutmoler, 2003).

When an animal is subjected to vaccination, both humoral and cellular wing become activated and memory against them is induced. Later on when infectious agent enters the body, it effectively eliminates these agents from the vaccinates before the occurrence of the disease (Twomey et al., 1995).

Routine vaccination program of dairy animals against infectious diseases in developing countries is important for increasing milk production and reducing economic losses. Combined vaccination helps to reduce the cost of vaccination program per annum. In large animal, different combinations like FMD + HS (Joseph and Hedger, 1984), FMD+ Rinderpest (Hedger et al.,1986), FMD and rabies antigens (Palanisamy et al., 1992) have been tried effectively. In many South and South- East Asian Countries FMD, HS and Black Quarter (BQ) vaccines are commonly used (Srinivasan et al. 1997). In combine vaccine trial, the antibody response of vaccinate to either of pathogen is either better or equivalent. The results indicate that the antigens in combined vaccines are compatible to each other.

MATERIALS AND METHODS

Preparation of FMD Vaccine: Cryopreserved BHK-21 cells were obtained from Quality Operations Laboratory (QOL) University of Veterinary and Animal Sciences (UVAS), Lahore and revived for culturing in strict sterilized condition. The live cell percentage was calculated using hemo-cytometery method as described by Ghori et al. (2011). The cell suspension was diluted using growth medium to 2.5x105 cells per ml and 15 ml of the diluted cell suspension was transferred to each of the 25 cm2 roux flask. The flasks were incubated at 37degC for 48 hours. The flasks having complete monolayer were selected for the propagation of previously isolated and characterized FMD "O" type virus (OIE 2006). Biological titer (Tissue culture dose 50-TCID50) of "O" serotype of FMD virus was determined as described by Reed and Munch (1938). The FMD virus "O" type suspension was inactivated using binary ethyleneimine (Bahnemann, 1975).

The inactivated virus suspension was admixed with Thiomersal sodium at rate of 0.05 percent and then with aluminum hydroxide gel to obtain 2% final concentration in the vaccine (Ilyas et al. 2004). Quality control procedures were carried out as described by Muhammad et al. (2011). The vaccine thus prepared, was transferred into properly labeled vials and stored at 40 C in the refrigerator till use.

Preparation of Hemorrhagic Septicemia Vaccine: The pure, identified and characterized culture of Pasteurella multocida was inoculated into the fermenter containing casein sucrose yeast (CSY) broth (OIE 2009; Sarma,1980). The prepared medium in fermenter vessel was sterilized by autoclaving at 121oC for 15 minutes and vessel was attached with bio-fermenter. The temperature, pH, BOD was adjusted at 37C0, 7.4 and 100%, respectively, using control panel of the fermenter. The fermenter was run for 24 hours. Biological titer of the bacteria was determined in terms of dry mass and total viable bacterial count. For inactivation of the bacterial culture formaldehyde (37%) was added in the culture at the rate of 0.5% and the culture flask was incubated at 37 0C for 24 hours. Quality control procedures were carried out as guided by OIE, (2009). Alum based Hemorrhagic Septicemia Vaccine (AHSV) was prepared from the inactivated mass culture by the technique as described by Ali et al. (2000).

Preparation of Multivalent Vaccine: Inactivated Foot and Mouth Disease Virus suspension and Pasteurella multocida culture were mixed together at the rate of 106 units of TCID50 and 2.2mg/dose, respectively at 4C0 for 10 minutes. Thiomersal sodium was mixed at the rate of 0.05% of the final volume. Alum gel was added as described in Muhammad (2012). Finally, the total volume was adjusted with sterilized phosphate buffer saline at the pH of 7.2-7.4.

Vaccination Trial: Twelve rabbits (6 months of age) were divided into four groups. Each group contained three rabbits. Vaccines i.e. alum precipitated Pasteurella multocida (AHSV), Foot and Mouth Disease Virus "O" type Vaccine (FMDV), and multivalent HS and FMD

vaccine (HS-FMD) was injected in the rabbits of group A, B, C, respectively while the fourth group (D) was control one (without vaccination).

Blood sample from each rabbit was collected on 0, 14, 28, 35 and 48 days post-priming. The serum from each of the blood sample was separated and stored in properly labeled vials at -40 0C for antibody titration through VN and IHA test as described by Lewis et al, (1991) and Das et al. (1998). The statistical analysis was performed by calculating the Geometric Mean Titer (GMT) of antibodies against each of the vaccine.

RESULTS AND DISCUSSION

Antibody response of rabbits (group A) to FMD vaccine was determined through V/N test using reference serotype obtained from UVAS, Lahore, Pakistan and results are shown in Table 1. The geometric mean anti- FMDV "O" V/N antibody titer on 0, 14th, 28th, 35th and 48th day post priming were 0, 10.1, 50.8, 20.2 and 12.7 units, respectively. The FMD vaccine when injected in the rabbits induces antigen presenting cells (APC) in the nearest lymph-node. The APC's present the antigen on their surface in association with self immune associated (Ia). The T cells recognize the antigen and transform into lymphoblast and populate in different lymph nodes and other lymphoid organs such as spleen, mucus membrane associated lymphoid tissues such as peyr's patches, etc., (Tizzard, 1998, Vanio et al. 1988; Muhammad et al.1993). The lymphocytes secrete cytokines which potentiate cell mediated immunity (Kenneth et al., 2004) as well as humoral immunity.

The serum antibody titer of the rabbits (group B) against LPS of P. multocida was determined and results are shown in Table-2. The antibody titer on 0, 14th, 28th,35th and 48th day post priming was 0, 6.4, 42.3, 21.3 and 10.6 IHA units, respectively. LPS of P. multocida is T cell independent antigen. The antigen does not present on surface of APC along with Ia of the animal body and hence the specific B cell alone respond to the LPS and transform into plasma cells. The B cell do not get cooperation of the T-cells, hence response of the plasma cells is primary and poor. The antibody response is of short duration (Abbas et al., 1991).

Antibody titers of rabbits (group C) against each of the immunogen of combined FMD+HS vaccine were measured and shown in Table 3. These were 0, 10.1, 32, 50.8 and 50.8 IHA units against LPS of P. multocida and 0, 12.7, 80.6, 101.6 and 161.3 units of VN antibody titer against FMD virus on 0, 14th. 28th 35th and 48th day post priming. The control group without vaccination showed zero titer against FMD virus and LPS of P. multocida. The antibody response of the rabbits against each immunogen of combined FMD+HS vaccine was higher than that of rabbits receiving monovalent vaccines. These finding are in agreement to that of Rajesh (2003), Afzal and Muneer (1990) who demonstrated that specific B cells respond directly to LPS of P. multocida and transform into plasma cells that secret immunoglobulin M (IgM).

Protein antigens of FMD virus are processed through APC along with Ia antigen and stimulate the Th cells for production of cytokines whose production is antigen specific but their action is antigen non-specific so cytokines activate the response of LPS stimulated B cells. In this way LPS specific B cells proliferate, differentiate, and transform into plasma cells and memory cells. The plasma cells secret higher level of immunoglobulins and animals may show boosting response to second immunization. The cytokines produced in response to FMD virus proteins augment humoral as well as cellular immunity against FMD and LPS of P. multocida (Lu et el., 1991). Combined vaccine containing FMD virus, rabies virus, P. multocida and Cl. Chauvoei antigens are effective to reduce the frequency and cost of vaccination Srinivasan et al., 2001).

Table 1:

###Post-Priming Anti-LPS-IHA###Anti-FMD-VN

###Samnling Day###antibody titer###antibody titer

1###0###0,0,0 (0)###0,0,0 (0)

2###14###0,0,0 (0)###16,8,8(10.1)

3###28###0,0,0 (0)###64,32,64 (50.8)

4###35###0,0,0 (0)###16,32,16 (20.2)

5###48###0,0,0 (0)###16,8,16(12.7)

Table 2: Antibody response of rabbits to HS vaccine

###Post-Priming###Anti-LPS-IHA###Anti-FMD-

###Sampling Day###antibody titer###YN antibody

###titer

1###0###0,0,0 (0)###0,0,0 (0)

2###14###64, 64, 64 (6.4)###0,0,0 (0)

3###28###64, 32, 32 (42.3)###0,0,0 (0)

4###35###16,16,32 (21.3)###0,0,0 (0)

5###48###8, 8, 16 (10.6)###0.0.0 (0)

Table 3: Antibody response of rabbits to combined FMD and HS vaccine

###Post-Priming###Anti-LPS-IHA###Anti-FMD-VN

###Sampling Day###antibody titer###antibody titer

1###0###0,0,0 (0)###0,0,0 (0)

2###14###16,8,8 (10.1)###16,16,8(12.7)

3###28###32,32,32 (32)###128,64,64 (80.6)

4###35###64,32,64 (50.8)###128,64,128

###(101.6)

5###48###64,64,32 (50.8)###128,256,128

###(161.3)

REFERENCES

Abbas, A. K., A. H. Litchman and J. S. Pober. (1991). Cellular and molecular immunology, W. B. Sunders Company, London, P: 417. Afzal, M., R. Muneer and G. Stein. (1991). Studies on the etiology of Hydro Pericardium Syndrome (Angara disease) in broilers. Vet. Rec., 128:591-593.

Ali, Z. K. Muhammad, I. Hussain and M. Arshad. (2000). Antibody response of buffaloes to haemorrhagic septicaemia vaccine. Int. J. Agri. Biol., 4(3):150-153.

Awan, F. N., M. A. Khan, K. Muhammad, M. Rabbani, M. Younus and R. M. Khawaja. (2009). Epidemiological investigation of foot and mouth disease in districts of punjab, Pakistan J. Zool., Suppl. Ser. No., 9: 179-185.

Bahnemann, H. G. (1975). Inactivation of viruses in serum with binary ethyleneimine. Clin Microbiol. 3(2): 209-210.

Das, P., K. Muhammad and M. A. Sheikh. (1998).Standardization of indirect haemagglutinationtest for monitoring Pasteurella multocida antibodies. Pakistan Vet. J., 18(1): 25-28.

Dietzschold, B. and R. Ahl. (1970). Characterization of Foot-and-Mouth Disease Virus Ribonucleic Acid Synthesized in vitro. J. Gen. Virol., 8: 73-76; DOI 10.1099/0022-1317-8-1-73.

Ghori, M. T., K. Muhammad and M. Rabbani. (2011).Physical Factors Affecting in Vitro Replication of Foot and Mouth Disease Virus (Serotype "O"). Pakistan Vet. J., 31(4): 313-316.

Hedgher, R. S., W. P. Taylor, I. T. R. Barnett, R. Reik, D. Harphan. (1986). Simultaneous vaccination ofcattle against Foot and Mouth Disease andRinderpest. Trop. Anim. Hlth. Prod., 18: 21-25.

Ilyas, M. A., I. M. Hussain, M. Siddique and M. S.Mahmood. (2004). An Aluminium Hydroxide Gel Adsorbed Inactivated Egg Drop Syndrome Vaccine., Int. J. Poul. Sci., 3(4): 279-283.

Joseph, P. G. and R. S. Hedger. (1984): Serological response of cattle to simultaneous vaccination against Foot and Mouth Disease and Haemorrhagic Septicaemia. Vet. Rec., 114: 494-496.

Kenneth, C., McCullough and F. Sobrino. (2004). Immunology of Foot and Mouth Disease (abstract). In Foot and Mouth Disease: Current Perspective. Khawaja, R. M., K. Muhammad, W. Shahzad, I Hussain, Z. I. Choudhry, F. N. Awan, A. Bukhari, I. Altaf and A. Hanif. (2009). Isolation, adaptation and sero-typing of local strains of foot and mouth disease virus. Pakistan J. Zool., Suppl. S# 9: (Part II): 173-177.

Lewis, S. A., D. O. Morgan and M. J. Grubman. (1991). Expression, processing, and assembly of Foot- and Mouth Disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol., 65(12): 6572-6580.

Lu, Y. S., W. C. Lai, S. P. Pakes and C. Stefanu. (1991).The outer membrane of Pasteurella multocida 3: A protects rabbits against homologous challenge. Infect. Immun., 59(12): 4517-4523.

Muhammad, K. (1993). In vitro studies of chicken macrophages and their role in Salmonella related immunization failure. Ph.D. Thesis. School of Biological Sciences, Uni. Surrey, Surrey, U.K.

Muhammad, K. (2012). Augmentation of combined oil based Foot and Mouth Virus ('O', "A" and "Asia-1") and Hemorrhagic Septicemia vaccine production potential and immunoprophylaxis of buffalo and cattle against the diseases. Final technical and financial report, Department of Microbiology, University of Veterinary and Animal Sciences, Lahore,Muhammad, K., Z. I. Chaudhry, M. Rabbani, I. Altaf, M. A. Tariq and M. Anees. (2011). Isolation, characterization and monitoring of antibiotic resistance in Pasteurella Multocida isolates from buffalo (Bubalus bubalis) herds around Lahore. Pakistan J. Zool., 43(2): 249-254.

OIE. (2006). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

OIE. (2009). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.Palanisamy, R., A. P. Kalanidhi, K. Nagaiah and V. A.Srinivasan. (1992). Screening of Indian elephants, cattle, and sheep for antibodies to Foot and Mouth Disease virus infection associated antigen. Ind. Vet. J., 69: 390-392.

Pereira, H. G. (1981). Foot and Mouth Disease virus. In Gibbs, R.P.G. (ed.), Virus Diseases of Food Animals.Vol.2. Academic Press, New York, NY, pp: 333-363.

Rajesh, N., A. Fondevila, N. B. Pereyra, F. Cane, O.Ibarra, A. G. Lopez, H. Piscitelli, V. K. Donnell and E. Smitsaart. (2003). Immune response tests in pigs vaccinated against Foot and Mouth Disease. Veterinaria-Argentina. 12: pp: 23-29.

Reed, L. J. and H. Muench. (1938). A simple method for estimating fifty percent end point. Am. J. Hyg.,27: 493-497.

Salt, S., S. J. Cox, P. V. Barnett and P. Dani. (1999).Emergency vaccination of sheep against foot- and-mouth disease: protection against disease and reduction in contact transmission. Vaccine,17: 1858-1868.

Sarma, G. and B. R. Boro. (1980). Isolation of Pasteurella multocida from sporadic outbreaks of bovine pasteurellosis in Assam, Vet. Rec.,106(3): 57-58.

Srinivasan1, V. A., G. S. Reddy1, K. A. Rao1 and U.Kihm. (2001). Serological response of bovines to combined vaccine containing Foot and Mouth Disease virus, Rabies virus, Pasteurella multocida and Clostridium chauvoei antigens. Vet. Arch., 71(1): 37-45.

Sutmoller, P. (2003). Control and eradication of FMDV.Virus Res., 91: 101-144.Tizzard, I. R. (1998). Veterinery immulogy, Saunders, Philadelphia, USA, 8th edn, 2008, ISBN 1416049894.

Twomey, T., J. Newman, T. Burrage, P. Piatti, J. Lubroth and F. Brown. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines. Vaccine. 13(16): 1603-1610.

Vanio, O., T. Veromaa, E. Verola, P. Toivenen and M. J.H. Ratecliffe. (1988). Antigen presenting cell- T cell interaction in chicken is MHC class-II antigen restricted. J. Immunol., 140: 2864-2868.
COPYRIGHT 2012 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Altaf, I.; Siddique, M.; Muhammad, K.; Irshad, M.; Khan, M.Z.; Anjum, A.A.; Kamran, M.
Publication:Journal of Animal and Plant Sciences
Article Type:Report
Geographic Code:9PAKI
Date:Jun 30, 2012
Words:2848
Previous Article:ETHNOBOTANICAL STUDY ABOUT MEDICINAL PLANTS OF POONCH VALLEY AZAD KASHMIR.
Next Article:RHUS CORIARIA LINN, A PLANT OF MEDICINAL, NUTRITIONAL AND INDUSTRIAL IMPORTANCE: A REVIEW.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters